GCFLU Trademark

Trademark Overview


On Friday, April 28, 2017, a trademark application was filed for GCFLU with the United States Patent and Trademark Office. The USPTO has given the GCFLU trademark a serial number of 79213938. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 13, 2024. This trademark is owned by GREEN CROSS CORPORATION. The GCFLU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating the central nervous system; [ Radioactive pharmaceutical preparations for in vivo and in vitro diagnostic use; Pharmaceutical preparations for anus; ] Antibiotic preparations; [ Hypoglycemic agents; ] Pharmaceutical preparations for treating blood disorders; [ Blood plasma; Medicated serums for treatment of hair, skin and lips; Serotherapeutic medicines for the treatment and prevention of infectious diseases caused by bacteria or viruses; ] Pharmaceutical preparations for respiratory organs; Biological preparations for medical or veterinary purposes, namely, for the treatment and prevention of infectious diseases caused by bacteria or viruses; Cultures of microorganisms for medical purposes, except yeast; Pharmaceutical preparations for treatment of infectious diseases caused by bacteria or viruses; [ Pharmaceutical preparation for skin care; ] Human vaccine preparations; Vaccines against flu; Pharmaceutical agents affecting sensory organs; Phar...
gcflu

General Information


Serial Number79213938
Word MarkGCFLU
Filing DateFriday, April 28, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 13, 2024
Registration Number5477855
Registration DateTuesday, May 29, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2018

Trademark Statements


Certificate of Correction for RegistrationIn the statement, Class 5, has been updated in accordance with the F-note dated 3/8/2021.
Goods and ServicesPharmaceutical preparations for treating the central nervous system; [ Radioactive pharmaceutical preparations for in vivo and in vitro diagnostic use; Pharmaceutical preparations for anus; ] Antibiotic preparations; [ Hypoglycemic agents; ] Pharmaceutical preparations for treating blood disorders; [ Blood plasma; Medicated serums for treatment of hair, skin and lips; Serotherapeutic medicines for the treatment and prevention of infectious diseases caused by bacteria or viruses; ] Pharmaceutical preparations for respiratory organs; Biological preparations for medical or veterinary purposes, namely, for the treatment and prevention of infectious diseases caused by bacteria or viruses; Cultures of microorganisms for medical purposes, except yeast; Pharmaceutical preparations for treatment of infectious diseases caused by bacteria or viruses; [ Pharmaceutical preparation for skin care; ] Human vaccine preparations; Vaccines against flu; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting metabolism; Veterinary preparations for the treatment and prevention of infectious diseases caused by bacteria or viruses; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for immunity adjustment; [ Pharmaceutical preparations for urogenital organs; Vitamin preparations; Preparations of trace elements for human and animal use, namely, nutritional supplements and vitamins for the treatment and prevention of infectious diseases caused by bacteria or viruses; Crude medicines for the treatment and prevention of infectious diseases caused by bacteria or viruses; Anti-inflammatory preparations; ] Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; [ Steroids; ] Allergy medications; Nutritional supplements, namely, nutritional supplements in tonic form and for use as alteratives for medical purposes; Pharmaceutical preparations for tumor treatment; Pharmaceutical preparations acting on the central nervous system

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 13, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGREEN CROSS CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameGREEN CROSS CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameGREEN CROSS CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Tuesday, August 15, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, August 16, 2017NON-FINAL ACTION WRITTEN
Thursday, August 17, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 10, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 11, 2017ASSIGNED TO EXAMINER
Friday, September 8, 2017REFUSAL PROCESSED BY IB
Tuesday, October 31, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 18, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, January 18, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, January 18, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 18, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, February 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 18, 2017REFUSAL PROCESSED BY MPU
Friday, August 18, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 31, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, August 29, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, September 14, 2018FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 6, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 16, 2021ASSIGNED TO PARALEGAL
Friday, September 14, 2018FINAL DISPOSITION PROCESSED
Sunday, February 28, 2021LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, March 16, 2021CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, March 16, 2021LIMITATION FROM THE IB EXAMINED AND ENTERED
Monday, May 29, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 13, 2024CANCELLED SECTION 71
Monday, April 4, 2022INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Tuesday, November 16, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED